Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Category > Report Information Email a colleague | Printer format

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III

BioInformatics, LLC
May 1, 2009
175 Pages - Pub ID: BIF2476768
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Related Reports


The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume III, is part three of BioInformatics LLC’s on-going analysis of the market for antibodies. One thousand scientists completed a 35-question survey fielded between April 28 and May 6, 2009 — making this the most current information available pertaining to the antibody market today. This report is designed to enable suppliers to be responsive to scientists’ expectations - and preferences - as regards to selection, availability, delivery time, pricing and supplier/brand. The findings in this study will offer insight as to a supplier’s competitive standing, and provide direction as to how fine-tune product offerings and move into the position of scientists’ supplier of choice.

Related Reports:
Monoclonal antibodies: 2009 update
Freedonia Focus on Biologicals
Regenerative Medicines: Bone and Joint Applications
Forecast Insight: Top 20 Cancer Therapy Brands Targeted therapies will drive market growth in the wake of the cytotoxic and antihormonal patent cliff
Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach
Bioarrays for Life Science Research, Diagnostics and Drug R&D
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
Competitor Analysis: Immunotoxins
Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV)
Monoclonal Antibody Therapeutics 2009-2024

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 4